Actively managed fund

Candriam Eqs L Biotech R GBP Cap

ISIN
LU1269736911

How good is this fund, really?

See the rating in the app

About Candriam Eqs L Biotech R GBP Cap

Candriam's Biotechnology fund is an actively managed Luxembourg UCITS sub-fund that buys shares of biotechnology companies around the world. Managers screen firms in two steps, first judging how convincing the available clinical data is, then scoring management quality, growth potential, competitive position, value creation and indebtedness. The NASDAQ Biotechnology Index (Net Return) serves as a reference universe, and while most holdings come from it, outside names are allowed. ESG screening leaves out companies that fall short of recognised international standards. This R share class is sterling-denominated and accumulating. Its key information document shows a risk indicator of 5 of 7, a 6-year holding period and an ongoing charge of 1.13%.

Watch this fund for free Add Candriam Eqs L Biotech R GBP Cap to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Candriam Eqs L Biotech R GBP Cap — platforms and fees

Sold on 3 platforms we follow.

Candriam Eqs L Biotech R GBP Cap — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds